TP-6379

N/A

Report date: 2023/06/19 15:44:35
NME

Base Information

Drug NameTP-6379
Drug Alias NameTP-6379
ClassificationSmall molecules
Mechanisms of ActionTransforming growth factor beta receptor 1 inhibitors
TargetsTransforming growth factor beta receptor 1
Therapy Area/IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSumitomo Pharma Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Pharma Oncology Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A